Breast carcinoma in situ incidence rates (European age-standardised
For breast cancinoma in situ, like most cancer types, differences between countries largely reflect risk factor prevalence in years past.
Breast Carcinoma in situ (D05), Average Number of New Cases Per Year, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK, 2016-2018
|AS Rate - 95% LCL||25.8||16.3||26.0||28.4||25.2|
|AS Rate - 95% UCL||26.5||18.1||29.0||32.6||25.9|
|AS Rate - 95% LCL||0.1||0.0||0.1||0.0||0.1|
|AS Rate - 95% UCL||0.1||0.1||0.3||0.2||0.1|
|AS Rate - 95% LCL||13.3||8.5||13.5||14.7||13.1|
|AS Rate - 95% UCL||13.7||9.5||15.0||16.9||13.4|
Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, July 2021. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
Data were provided by ISD Scotland on request, April 2020. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
Data were published by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales https://phw.nhs.wales/services-and-teams/welsh-cancer-intelligence-and-surveillance-unit-wcisu/cancer-incidence-in-wales-2002-2018/, March 2021.
Data were provided by the Northern Ireland Cancer Registry on request, May 2020. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
About this data
Data is for UK, 2016-2018, ICD-10 D05.